A placebo-controlled, single-blind study that appeared in the Journal of Trace Elements in Medicine and Biology (epublshed ahead of print May 11, 2011) looked at chromium supplementation in 40 patients recently diagnosed with type 2 diabetes. Subjects were given either a placebo or nine grams of brewer’s yeast (containing 42 mcg of chromium) for a period of three months. Those in the treatment group experienced improvements in fasting blood sugar levels (197.6 prior to treatment and 103.7 after treatment) and in hemoglobin A1c levels (9.5 prior to treatment, 6.9 after). Triglycerides and cholesterol levels were also lower in the treatment group.